DPP4 and Hyperglycemia: The goal of this work was to evaluate the effect of linagliptin + insulin compared to that of insulin alone on glycemic control and prognosis in hospitalized patients with SARS-CoV-2 infection and hyperglycemia, hypothesizing that the use of DPP-4 inhibitor would improve metabolic control and clinical prognosis.